Abstract:Aβ, a major peptide deposited in neuritic plaques, has been considered as an important initiating molecule in the pathogenesis of AD. Binding of Aβ to ABAD distorts the enzyme’s structure and modifies its functions in metabolic homeostasis related to energy metabolism and catabolism of isoleucine branched-chain fatty acids. Thus, the blockade of ABAD/Aβ interaction using ABAD-DP may be a potential therapeutic strategy for AD. Our coworkers previously established a fusion peptide fragment, ABAD-DP-6His, NT4, TAT, by fusing a 6-His protein to the 5′ end of ABAD-DP cDNA in the adeno-associated viral vector (AAV), constructed rAAV/NT4-TAT-6His-ABAD-DP (rAAV/NTA). We detected the place navigation task and spatial probe test by Morris Water Maze(MWM) in the way of intranasal administration. And tested the APP and Aβ1-42 expression by immunolhistochemical method; In the 7, 9, 11 months of mice age, we tested the senile plaques(SP) and apotosis expression by congon red staining and hematoxylin-eosin staining (HE staining). 1. There is no statistical differences among gropes (P>0.05), in the 5 or 7 months of mice age; but in the 9, 11 months, prolonged the escape latency of place navigation test in APP grope compare with normal control grope (P<0.05&P<0.01). In the 9, 11 months of mice age, reduced the frequency of APP grope compare with the control grope in spatial probe test (P<0.05&P<0.01), increased the frequency of rAAV/NTA grope compare with the APP grope in spatial probe test (P<0.01&P<0.01). 2. In the 5 months of mice age, there is the significant difference of APP positive expression among gropes, the APP positive expression is markable increased in APP695 mice than the C57 mice; In the 5, 7, 9, 11 months of mice age, the Aβ1-42 positive expression of APP grope are more than control grope and rAAV/NTA grope; In the 5, 7, 9, 11 months of mice age, the SP and apoptosis cells are increased in APP grope compare with the control grope and rAAV/NTA grope. The recombinant adeno-associated virus system fusing with ABAD-DP could protect the behavior and pathology changes in AD.

Intranasal TAT-haFGF Improves Cognition and Amyloid-β Pathology in an AβPP/PS1 Mouse Model of Alzheimer’s Disease

Intranasal Administration of TAT-haFGF14–154 Attenuates Disease Progression in a Mouse Model of Alzheimer’s Disease

Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.

Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model

Tat-Hafgf(14-154) Upregulates Adam10 To Attenuate The Alzheimer Phenotype Of App/Ps1 Mice Through The Pi3k-Creb-Ire1 Alpha/Xbp1 Pathway

Tat-haFGF 14–154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice Through the PI3K-CREB-IRE1α/XBP1 Pathway

Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway

Brain Targeting and Aβ Binding Bifunctional Nanoparticles Inhibit Amyloid Protein Aggregation in APP/PS1 Transgenic Mice.

Experimental Research of Fucong Tang Improving Learning and Memory Abilities in APP/PS1 Double Transgenic Mice with Alzheimer's Disease

Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.

Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.

Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer’s disease mouse model

AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease

Evaluation of the Safety and Brain-Related Tissues Distribution Characteristics of Tat-Hafgf Via Intranasal Administration

Self-assembling Nanofibers Improve Cognitive Impairment in a Transgenic Mice Model of Alzheimer's Disease

RESEARCH ON THE NEUROPROTECTIVE EFFECT OF AD WITH THE RECOMBINANT ADENO-ASSOCIATED VIRUS SYSTEM FUSING WITH ABAD-DP

Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats.

Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model

Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease

Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) Through Autophagy Induced by Activating Axl

A Novel Aβ B-Cell Epitope Vaccine (rCV01) for Alzheimer’s Disease Improved Synaptic and Cognitive Functions in 3 × Tg-AD Mice